Next Article in Journal
The Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and Treatment
Previous Article in Journal
How do Midwives and Physicians Discuss Childhood Vaccination with Parents?
Article Menu

Export Article

Open AccessCommunication
J. Clin. Med. 2013, 2(4), 260-263;

Cutaneous Cryptococcoma in a Patient on TNF-α Inhibition

PASE Healthcare, PC, 225 Millburn Avenue, Suite 303, The Common, Millburn, NJ 07041, USA
East Coast Advanced Plastic Surgery, 79 Hudson Street, Suite 700, Hoboken, NJ 07030, USA
Saint Joseph's Regional Medical Center, 703 Main Street, Paterson, NJ 07503, USA
Infectious Disease Center of New Jersey, 22 Old Short Hills Road, Suite 106, Livingston, NJ 07039, USA
Weill Cornell Medical Center, New York Presbyterian Hospital, 525 East 68th Street, New York, NY 10021, USA
These authors contributed equally to this work.
Author to whom correspondence should be addressed.
Received: 8 October 2013 / Revised: 1 November 2013 / Accepted: 15 November 2013 / Published: 22 November 2013
Full-Text   |   PDF [162 KB, uploaded 22 November 2013]   |  


An 87-year old Caucasian male with past medical history of rheumatoid arthritis (RA) and chronic kidney disease presents with left hand erythema, pain, tenderness, induration and edema. Clinically, these hand findings began proximal to the metacarpo-phalangeal joints and extended to the distal wrist. He was noted to have ipsilateral axillary lymph node enlargement but denied any constitutional signs or symptoms. Laboratory markers of inflammation were poor prognostic indicators due to relatively active RA, the use of chronic daily glucocorticoids and weekly adalimumab use. Oral antibiotics were administered with limited success leading to a skin biopsy which reported a hematogenously disseminated fungal panniculitis; cultures grew Cryptococcus neoformans, however, serum cryptococcal antigen was negative. With initial fluconazole treatment, skin findings and lymphadenopathy improved gradually over the next six months. However, the patient’s improvement stagnated and his condition reverted back to the state of initial presentation. View Full-Text
Keywords: panniculitis; Cryptococcus neoformans; adalimumab; TNF-α inhibitor; fluconazole panniculitis; Cryptococcus neoformans; adalimumab; TNF-α inhibitor; fluconazole

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Gomes, R.M.; Cerio, D.R.; Loghmanee, C.; McKinney, J.; Patel, M.; Miraglia, J.; Yousef-Bessler, M.; Zippin, J.H.; Schuetz, A.N.; Pinho, P.B. Cutaneous Cryptococcoma in a Patient on TNF-α Inhibition. J. Clin. Med. 2013, 2, 260-263.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
J. Clin. Med. EISSN 2077-0383 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top